Replies to post #148230 on Innovation Pharmaceuticals Inc (IPIX)

[Phoenix300]

Horse pucky

[sox040713]

Last week's PR said it'll be unblinded this week and released next week.

#SADDER

so if not released tomorrow - Leo lied again? last week said it would be released within 1 week.

#SAD

[groton68]

Musk has repeatedly overpromised about Tesla. Hasn't hurt his stock. Do people call him a liar? no. They call him a visionary

[MinnieM]

You are incorrect:

From pr dated 5.11.16
http://cellceutix.com/data-from-phase-2-trial-of-prurisol-for-psoriasis-to-be-unblinded-next-week-top-line-results-to-follow/#sthash.z665YBWU.dpbs

is pleased to announce that the clinical database for the Phase 2 clinical trial of Prurisol for the treatment of mild-to-moderate chronic plaque psoriasis is expected to be “unblinded” next week. Once the blind is removed, data from each of the four arms of the trial (one placebo arm, three oral dosing regimens of Prurisol) will be reviewed and analyzed to evaluate the safety and efficacy of Prurisol. Cellceutix expects to release top-line data from the study approximately one week after the blind is removed.

Following is the way I look at the calendar since it might not even be unblinded until tomorrow. This way I'll be thrilled if it's early:

Click on calendar to enlarge.









In Reply to 'MXAMDUD'
so if not released tomorrow - Leo lied again? last week said it would be released within 1 week.

#SAD

[CallMeCrazy]

You should read more carefully.

... the treatment of mild-to-moderate chronic plaque psoriasis is expected to be "unblinded" next week.

https://finance.yahoo.com/news/data-phase-2-trial-prurisol-133000335.html

[cascott]

wait, just to be clear, YOU ARE COMMENTING ON SOMEONE LYING?

[Bruinfan4ever]

If I owned 134,000 shares, I would at least know how to read a PR. LMAO

[williamssc]

PR From May 11 (last week) "Phase 2 clinical trial of Prurisol for the treatment of mild-to-moderate chronic plaque psoriasis is expected to be "unblinded" next week. Once the blind is removed, data from each of the four arms of the trial (one placebo arm, three oral dosing regimens of Prurisol) will be reviewed and analyzed to evaluate the safety and efficacy of Prurisol. Cellceutix expects to release top-line data from the study approximately one week after the blind is removed".

#poundsand